title: Neural agrin activates a high-affinity receptor in C2 muscle cells that is unresponsive to muscle agrin.
abstract: During synaptogenesis, agrin, released by motor nerves, causes the clustering of acetylcholine receptors (AChRs) in the skeletal muscle membrane. Although muscle alpha-dystroglycan has been postulated to be the receptor for the activity of agrin, previous experiments have revealed a discrepancy between the biological activity of soluble fragments of two isoforms of agrin produced by nerves and muscles, respectively, and their ability to bind alpha-dystroglycan. We have determined the specificity of the signaling receptor by investigating whether muscle agrin can block the activity of neural agrin on intact C2 myotubes. We find that a large excess of muscle agrin failed to inhibit either the number of AChR clusters or the phosphorylation of the AChR induced by picomolar concentrations of neural agrin. These results indicate that neural, but not muscle, agrin interacts with the signaling receptor. Muscle agrin did block the binding of neural agrin to isolated alpha-dystroglycan, however, suggesting either that alpha-dystroglycan is not the signaling receptor or that its properties in the membrane are altered. Direct assay of the binding of muscle or neural agrin to intact myotubes revealed only low-affinity binding. We conclude that the signaling receptor for agrin is a high-affinity receptor that is highly specific for the neural form.
authors.affiliation: Regeneron Pharmaceuticals, Tarrytown, New York 10591, USA.
authors.forename: D C
authors.initials: DC
authors.lastname: Bowen
authors.forename: J
authors.initials: J
authors.lastname: Sugiyama
authors.forename: M
authors.initials: M
authors.lastname: Ferns
authors.forename: Z W
authors.initials: ZW
authors.lastname: Hall
mesh_terms: D018171:Agrin / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D001667:Binding, Competitive / Q000502:physiology; D002460:Cell Line / Q000737:chemistry / Q000502:physiology; D003101:Collodion; D003598:Cytoskeletal Proteins / Q000187:drug effects / Q000378:metabolism; D049030:Dystroglycans; D016189:Dystrophin / Q000187:drug effects / Q000378:metabolism; D007536:Isomerism; D008562:Membrane Glycoproteins / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D018485:Muscle Fibers, Skeletal / Q000737:chemistry* / Q000378:metabolism / Q000502:physiology; D018482:Muscle, Skeletal / Q000166:cytology; D009469:Neuromuscular Junction / Q000737:chemistry / Q000502:physiology; D010766:Phosphorylation; D051381:Rats; D011950:Receptors, Cholinergic / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D011994:Recombinant Proteins / Q000378:metabolism / Q000494:pharmacology; D012680:Sensitivity and Specificity; D015398:Signal Transduction / Q000502:physiology; D014101:Torpedo
chemical_list: D018171:Agrin; D003598:Cytoskeletal Proteins; D016189:Dystrophin; D008562:Membrane Glycoproteins; D011950:Receptors, Cholinergic; D011994:Recombinant Proteins; D049030:Dystroglycans; D003101:Collodion